SCHEMBL9762330

SCHEMBL9762330

Cn1cncc1CN1OCCC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 4/20 0.43
LMNA P02545 3/20 0.41
CHRM4 P08173 3/20 0.41
CHRM1 P11229 3/20 0.41
CHRM3 P20309 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C9 P11712 2/20 0.41
CHRM2 P08172 2/20 0.41
CYP2A6 P11509 1/20 0.41
CNR1 P21554 1/20 0.41
HTR2A P28223 1/20 0.41
CYP2A13 Q16696 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9761609 0.74 CHRM5 (0.41) CHRM5LMNACHRM4CHRM1CHRM3
SCHEMBL9762539 0.72 CHRM2 (0.36) CHRM5CHRM4CHRM1CHRM3CHRM2
SCHEMBL9762485 0.71 CHRM2 (0.38) CHRM5CHRM4CHRM1CHRM3CHRM2
SCHEMBL2328317 0.71 PIK3CD (0.41) CHRM5MAPK1KMT2A
SCHEMBL9762101 0.71 CYP2C9 (0.41) CHRM5CHRM4CHRM1CHRM3CYP2C9
SCHEMBL9761755 0.70 CHRM2 (0.37) CHRM5CHRM4CHRM1CHRM3CHRM2
SCHEMBL9762390 0.69 CHRM5 (0.42) CHRM5LMNACHRM4CHRM1CHRM3
SCHEMBL9762141 0.68 KDM4E (0.39) CHRM5CHRM4CHRM1CHRM3CYP3A4
SCHEMBL17525567 0.66 MEN1 (0.42) CHRM5LMNACHRM4CHRM1CHRM3
SCHEMBL9760860 0.66 LOXL2 (0.39) CHRM5CHRM4CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5066665-A Cognition activators; alzheimer*s disease WARNER-LAMBERT CO. (US) 1991-11-19 US claimed
US-5066665-A Cognition activators; alzheimer*s disease WARNER-LAMBERT CO. (US) 1991-11-19 US disclosed